CIBC World Market’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.04M Buy
120,661
+38,114
+46% +$2.25M 0.01% 521
2026
Q2
$4.63M Buy
82,547
+35,121
+74% +$1.83M 0.01% 627
2026
Q1
$2.28M Buy
+47,426
New +$2.08M ﹤0.01% 730
2025
Q2
– Sell
-11,023
Closed -$343K – 1464
2025
Q1
$343K Sell
11,023
-18,256
-62% -$579K ﹤0.01% 1126
2024
Q4
$747K Buy
29,279
+3,979
+16% +$106K ﹤0.01% 946
2024
Q3
$716K Buy
25,300
+1,653
+7% +$45.8K ﹤0.01% 898
2024
Q2
$624K Buy
23,647
+7,895
+50% +$219K ﹤0.01% 907
2024
Q1
$478K Buy
+15,752
New +$464K ﹤0.01% 997

Other funds holding RPRX

CIBC World Market's RPRX Position: Q3 2026 in Review

CIBC World Market increased its Royalty Pharma (RPRX) stake by 46% in Q3 2026, buying an estimated $2.25M and bringing the position to 120,661 shares worth $7.04M. The position accounts for 0.01% of the portfolio, ranked #521.

CIBC World Market first reported a position in RPRX in Q1 2024 and has held it in 8 quarters since. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • CIBC World Market held 120,661 shares of Royalty Pharma worth $7.04M as of Q3 2026.
  • CIBC World Market bought 38,114 Royalty Pharma shares in Q3 2026, an estimated $2.25M.
  • Royalty Pharma made up 0.01% of CIBC World Market's portfolio in Q3 2026, its #521 holding.
  • CIBC World Market first reported a position in Royalty Pharma in Q1 2024 and has held it in 8 quarters since.
  • 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on CIBC World Market's 13F filing for Q3 2026, filed 10 Nov 2026.